Chimeric Antigen Receptors With Bcma Specificity And Uses Thereof - EP4324851
The patent EP4324851 was granted to Regeneron Pharmaceuticals on Aug 27, 2025. The application was originally filed on Jul 18, 2019 under application number EP23215003A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4324851
- Application Number
- EP23215003A
- Filing Date
- Jul 18, 2019
- Status
- Granted And Under Opposition
- Jul 25, 2025
- Grant Date
- Aug 27, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents